We included men with PSA 3-10ng/mL who had histologically-confirmed prostate cancer after receiving a biopsy from a large UK-wide population-based case-control study (nested within the case-finding phase of the Prostate testing for cancer and Treatment (ProtecT) randomised controlled trial)[10,11]. Here, KLK3 is linked to prostate carcinoma.